Lee Brian P, Azimi Parvin H, Staat Mary Allen, Louie Leslie, Parada Ester, Berke Tamas, Ward Richard L, Bernstein David I, Matson David O
Children's Hospital and Research Center at Oakland, Oakland, CA, USA.
Pediatr Infect Dis J. 2005 Nov;24(11):984-8. doi: 10.1097/01.inf.0000183754.29707.cd.
As the most common cause of severe diarrhea among children, rotavirus has a significant economic impact. Previous studies focused on the direct medical costs of rotavirus infections; however, nonmedical costs account for the majority of the financial burden from this disease. Herein, we report the results from the largest prospective study in the United States determining the nonmedical costs of severe rotavirus infections.
Prospective, active, gastroenteritis case surveillance was conducted between November 1997 and December 1999 at 3 pediatric medical centers. Rotavirus infection was identified for 548 children admitted between 2 weeks and 5 years of age. Detailed information about nonmedical costs during the prehospitalization, hospitalization and posthospitalization periods was obtained through interviews.
The average nonmedical cost per case of rotavirus disease was USD $448.77, including $359.04 for missed work, $56.66 for transportation, $11.90 for oral rehydration solutions, $9.59 for diapers, $6.83 for child care changes, $3.82 for special foods and $0.93 for formula changes. More than one-half of these expenses (53%) occurred outside the hospitalization period, and 80% of the cost was attributable to missed work.
With an estimated 50,000 hospitalizations attributable to rotavirus each year in the United States, the nonmedical costs of severe rotavirus infections may exceed USD $22 million annually. Previous cost effectiveness analyses of rotavirus vaccines substantially underestimated this burden, suggesting that the nonmedical costs associated with mild to moderate rotavirus disease have been similarly underestimated. These findings are needed to assess accurately the cost effectiveness of future rotavirus immunization strategies.
作为儿童严重腹泻的最常见病因,轮状病毒具有重大的经济影响。以往的研究主要关注轮状病毒感染的直接医疗费用;然而,非医疗费用占该疾病经济负担的大部分。在此,我们报告美国最大的一项前瞻性研究结果,该研究确定了严重轮状病毒感染的非医疗费用。
1997年11月至1999年12月期间,在3家儿科医疗中心进行了前瞻性、主动的胃肠炎病例监测。确定了548名年龄在2周龄至5岁之间入院的儿童感染了轮状病毒。通过访谈获取了住院前、住院期间和出院后非医疗费用的详细信息。
每例轮状病毒疾病的平均非医疗费用为448.77美元,包括误工费用359.04美元、交通费用56.66美元、口服补液盐费用11.90美元、尿布费用9.59美元、儿童护理变更费用6.83美元、特殊食品费用3.82美元和配方奶粉变更费用0.93美元。这些费用中超过一半(53%)发生在住院期间之外,且80%的费用归因于误工。
在美国,估计每年有50000例住院病例归因于轮状病毒,严重轮状病毒感染的非医疗费用每年可能超过2200万美元。以往对轮状病毒疫苗的成本效益分析大大低估了这一负担,表明与轻度至中度轮状病毒疾病相关的非医疗费用也同样被低估。需要这些研究结果来准确评估未来轮状病毒免疫策略的成本效益。